Blog

Eli Lilly’s Bold Vision: Transforming Healthcare Through Weight-Loss Success and Innovation

Hannah Perry | February 21, 2025

Eli Lilly’s Transformation and Future Aspirations The recent boom in weight-loss medications has catapulted Eli Lilly (LLY) into the role of the largest healthcare company globally, primarily due to its popular drug, Zepbound. In the wake of this success, Eli Lilly is setting its sights on broader health challenges, aiming to leverage its profits to…

Medicare Under Threat: How Elon Musk’s DOGE Team Could Change Your Coverage Forever

Hannah Perry | February 20, 2025

Medicare Is in DOGE’s Crosshairs: What You Need to Know Introduction The landscape of Medicare, which provides essential health insurance coverage to more than 66 million Americans—including seniors and individuals with disabilities—may soon be impacted by sweeping changes, as the team associated with Elon Musk’s DOGE is spotlighting budget savings across the federal government. This…

Johnson & Johnson’s $10 Billion Baby Powder Settlement Faces Critical Legal Challenge

Hannah Perry | February 19, 2025

Johnson & Johnson Faces Crucial Test Over $10 Billion Baby Powder Settlement Bankruptcy Judge to Determine Outcome of Settlement Plan Johnson & Johnson (JNJ.N) is on the brink of a pivotal legal battle surrounding its **$10 billion proposal** aimed at settling numerous lawsuits that allege its baby powder product caused ovarian cancer. The outcome of…

Exploring the Diabetes Crisis in Indigenous Communities: Film, Innovation, and Solutions for Health Disparities

Hannah Perry | February 18, 2025

Exploring the Diabetes Crisis in Indigenous Communities Through the Lens of Film and Innovation In the Academy Award-nominated film Killers of the Flower Moon, lead actress Lily Gladstone portrays Osage-tribe resident Molly Burkhart, a woman grappling with diabetes. Set in the 1920s, the film highlights the challenges of managing a chronic disease that has disproportionately…

GSK Launches Penmenvy Vaccine: A Game Changer in the Fight Against Meningococcal Disease

Hannah Perry | February 17, 2025

GSK’s Penmenvy Vaccine Gains FDA Approval, Competing with Pfizer’s Offerings Introduction After two years of Pfizer holding the exclusive position with the only 5-in-1 meningococcal vaccine in the U.S. market, GSK is now set to enter the race with its newly approved Penmenvy vaccine. The Food and Drug Administration (FDA) approval permits its use in…

West Pharmaceutical Services Stock Drops 33% as Underwhelming 2025 Forecast Sparks Concerns

Hannah Perry | February 14, 2025

West Pharmaceutical Services Stock Plummets 33% After Disappointing Guidance West Pharmaceutical Services Inc. (WST) saw its stock plummet a staggering 33% on Thursday, leading the S&P 500 decliners. This historic drop marks the company’s largest single-day decline since it began trading data collection in March 1980. The severe downturn follows an announcement by the company…

Ozempic Revolutionizes Treatment for Alcohol Use Disorder: Promising Clinical Trial Results

Hannah Perry | February 13, 2025

Ozempic Shows Promise in Treating Alcohol Use Disorder Novo Nordisk’s renowned GLP-1 diabetes medication, Ozempic, has been spotlighted for its potential effects in reducing alcohol consumption, according to a recent small clinical trial. Conducted over a nine-week period, the study investigated the impact of Ozempic on individuals exhibiting moderately severe alcohol use disorder (AUD). The…

Four AI Trends Transforming Pharma and Healthcare by 2025: A Patient-Centric Revolution

Hannah Perry | February 12, 2025

A Big Leap Forward: Four AI Trends Disrupting Pharma and Healthcare in 2025 As we move towards 2025, companies in the pharmaceutical and healthcare sectors are gearing up to face mounting pressure to demonstrate tangible returns on their AI investments. Following a period of extensive AI experimentation in 2024, this shift will drive the adoption…

Health Brands Shine in Super Bowl LIX: Key Takeaways from Pharma Advertisements

Hannah Perry | February 11, 2025

Health Brands Take Center Stage During Super Bowl LIX Advertising Blitz As Super Bowl LIX concludes with the Philadelphia Eagles claiming victory, a spotlight shines on how various pharma and health advertisements performed during one of the most-watched events in the United States. Major health brands such as Pfizer, Novartis, and Hims & Hers showcased…

The Future of AbbVie After Humira: Navigating New Opportunities and Challenges in Pharma

Hannah Perry | February 10, 2025

The Future of AbbVie: Navigating Life After Humira For major pharmaceutical companies, the presence of blockbuster drugs can create an exhilarating yet precarious environment. The anticipation surrounding these lucrative treatments often leads to substantial excitement among investors, driving up share prices in expectation of impending revenues. Yet, the eventual reality of patent expirations and competition…

Next Page »